On Monday, Cardinal Health, Inc. (NYSE: CAH) opened higher 1.48% from the last session, before settling in for the closing price of $110.35. Price fluctuations for CAH have ranged from $86.70 to $116.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 9.33%. Company’s average yearly earnings per share was noted 1.39% at the time writing. With a float of $241.30 million, this company’s outstanding shares have now reached $244.00 million.
Let’s determine the extent of company efficiency that accounts for 48900 employees. In terms of profitability, gross margin is 3.22%, operating margin of 0.71%, and the pretax margin is 0.53%.
Cardinal Health, Inc. (CAH) Insider Activity
A key investor’s attitude towards the stock of the Medical Distribution industry is another important factor to consider. The insider ownership of Cardinal Health, Inc. is 0.28%, while institutional ownership is 89.93%. The most recent insider transaction that took place on Aug 21 ’24, was worth 1,812,920. In this transaction Chief Legal/Compliance Officer of this company sold 16,573 shares at a rate of $109.39, taking the stock ownership to the 75,971 shares. Before that another transaction happened on Aug 21 ’24, when Company’s Officer proposed sale 16,573 for $109.39, making the entire transaction worth $1,812,898.
Cardinal Health, Inc. (CAH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 1.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to -5.30% drop over the previous five years of trading.
Cardinal Health, Inc. (NYSE: CAH) Trading Performance Indicators
Check out the current performance indicators for Cardinal Health, Inc. (CAH). In the past quarter, the stock posted a quick ratio of 0.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.12. Likewise, its price to free cash flow for the trailing twelve months is 8.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.47, a number that is poised to hit 1.62 in the next quarter and is forecasted to reach 8.45 in one year’s time.
Technical Analysis of Cardinal Health, Inc. (CAH)
Looking closely at Cardinal Health, Inc. (NYSE: CAH), its last 5-days average volume was 1.88 million, which is a drop from its year-to-date volume of 2.11 million. As of the previous 9 days, the stock’s Stochastic %D was 72.68%. Additionally, its Average True Range was 1.78.
During the past 100 days, Cardinal Health, Inc.’s (CAH) raw stochastic average was set at 82.21%, which indicates a significant increase from 81.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.10% in the past 14 days, which was lower than the 18.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $108.22, while its 200-day Moving Average is $104.71. However, in the short run, Cardinal Health, Inc.’s stock first resistance to watch stands at $112.67. Second resistance stands at $113.35. The third major resistance level sits at $114.64. If the price goes on to break the first support level at $110.70, it is likely to go to the next support level at $109.41. Should the price break the second support level, the third support level stands at $108.73.
Cardinal Health, Inc. (NYSE: CAH) Key Stats
There are currently 243,567K shares outstanding in the company with a market cap of 27.09 billion. Presently, the company’s annual sales total 226,827 M according to its annual income of 852,000 K. Last quarter, the company’s sales amounted to 59,708 M and its income totaled 236,000 K.
